Linagliptin Inhibits Lipopolysaccharide-Induced Inflammation Concentration-Dependently And -Independently
Naoki Sato,1,2 Yuya Nakamura,1,3 Shiho Yamadera,4 Masahiro Inagaki,1,5 Sachiyo Kenmotsu,5 Hiroshi Saito,4,6 Tatsunori Oguchi,1 Mayumi Tsuji,1 Hirokazu Chokki,1 Isao Ohsawa,3 Hiromichi Gotoh,3 Shinichi Iwai,6 Yuji Kiuchi1 1Department of Pharmacology, Showa University School of Medicine, Shinagawa-ku,...
Saved in:
Main Authors: | Sato N (Author), Nakamura Y (Author), Yamadera S (Author), Inagaki M (Author), Kenmotsu S (Author), Saito H (Author), Oguchi T (Author), Tsuji M (Author), Chokki H (Author), Ohsawa I (Author), Gotoh H (Author), Iwai S (Author), Kiuchi Y (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2019-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Linagliptin Inhibits Interleukin-6 Production Through Toll-Like Receptor 4 Complex and Lipopolysaccharide-Binding Protein Independent Pathway in vitro Model
by: Saito H, et al.
Published: (2021) -
Linagliptin inhibits lipopolysaccharide-induced inflammation in human U937 monocytes
by: Shiho Yamadera, et al.
Published: (2018) -
The clinical application of linagliptin in Asians
by: Cao CQ, et al.
Published: (2015) -
Linagliptin: from bench to bedside
by: Doupis J
Published: (2014) -
Analytical Enantio-Separation of Linagliptin in Linagliptin and Metformin HCl Dosage Forms by Applying Two-Level Factorial Design
by: Sushant B. Jadhav, et al.
Published: (2016)